263. Cytokines Everywhere All at Once: Approach to CRS and ICANS
Get every episode summarized
Each time The Intern At Work: Internal Medicine publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
As a result of the rapid adoption CAR-T therapy for certain lymphoid malignancies and multiple myeloma, of these treatments, CRS and ICANS will become more common in IM wards in the coming years. Take a listen to learn about how to treat this emerging condition.
This episode was written by Dr. Veronica Ramirez (Internal Medicine Resident) and reviewed by Dr. Kelly Davison (Hematology) and Dr. Blair Schwartz (General Internist and Intensivist). Infographic by Neeloufar Grami (medical student).
Get every episode summarized
Each time The Intern At Work: Internal Medicine publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Intern At Work: Internal Medicine
Peering into the Pipes: Coronary Angiography
The Intern At Work: Internal Medicine
Untangling the Web – An approach to Cryptogenic Organizing Pneumonia
The Intern At Work: Internal Medicine
Overview of Lung Transplantation
The Intern At Work: Internal Medicine
De-Liver: It's Crucial
The Intern At Work: Internal Medicine